We conclude that active RAS inhibition by FTS was associated with attenuated fibrosis and improved muscle strength in the dy2J/dy2J mouse model of congenital muscular dystrophy. This evidence concerns the gene AKTIP and congenital muscular dystrophy due to LMNA mutation.